Stories written by

PBM Consolidation Concerns Medicine for Impacts on Drug Costs, Access - 03/03/2026

Low competition in the pharmacy benefit manager (PBM) market may drive higher costs with savings not fully passed to consumers. Medicine is vigilant as state and federal legislators have started addressing the entities’ evolving role.


PBM Consolidation Concerns Medicine for Impacts on Drug Costs, Access - 03/03/2026

Low competition in the pharmacy benefit manager (PBM) market may drive higher costs with savings not fully passed to consumers. Medicine is vigilant as state and federal legislators have started addressing the entities’ evolving role.


PBM Consolidation Concerns Medicine for Impacts on Drug Costs, Access - 03/03/2026

Low competition in the pharmacy benefit manager (PBM) market may drive higher costs with savings not fully passed to consumers. Medicine is vigilant as state and federal legislators have started addressing the entities’ evolving role.


PBM Consolidation Concerns Medicine for Impacts on Drug Costs, Access - 03/03/2026

Low competition in the pharmacy benefit manager (PBM) market may drive higher costs with savings not fully passed to consumers. Medicine is vigilant as state and federal legislators have started addressing the entities’ evolving role.


PBM Consolidation Concerns Medicine for Impacts on Drug Costs, Access - 03/03/2026

Low competition in the pharmacy benefit manager (PBM) market may drive higher costs with savings not fully passed to consumers. Medicine is vigilant as state and federal legislators have started addressing the entities’ evolving role.


PBM Consolidation Concerns Medicine for Impacts on Drug Costs, Access - 03/03/2026

Low competition in the pharmacy benefit manager (PBM) market may drive higher costs with savings not fully passed to consumers. Medicine is vigilant as state and federal legislators have started addressing the entities’ evolving role.


PBM Consolidation Concerns Medicine for Impacts on Drug Costs, Access - 03/03/2026

Low competition in the pharmacy benefit manager (PBM) market may drive higher costs with savings not fully passed to consumers. Medicine is vigilant as state and federal legislators have started addressing the entities’ evolving role.


PBM Consolidation Concerns Medicine for Impacts on Drug Costs, Access - 03/03/2026

Low competition in the pharmacy benefit manager (PBM) market may drive higher costs with savings not fully passed to consumers. Medicine is vigilant as state and federal legislators have started addressing the entities’ evolving role.


PBM Consolidation Concerns Medicine for Impacts on Drug Costs, Access - 03/03/2026

Low competition in the pharmacy benefit manager (PBM) market may drive higher costs with savings not fully passed to consumers. Medicine is vigilant as state and federal legislators have started addressing the entities’ evolving role.


PBM Consolidation Concerns Medicine for Impacts on Drug Costs, Access - 03/03/2026

Low competition in the pharmacy benefit manager (PBM) market may drive higher costs with savings not fully passed to consumers. Medicine is vigilant as state and federal legislators have started addressing the entities’ evolving role.


PBM Consolidation Concerns Medicine for Impacts on Drug Costs, Access - 03/03/2026

Low competition in the pharmacy benefit manager (PBM) market may drive higher costs with savings not fully passed to consumers. Medicine is vigilant as state and federal legislators have started addressing the entities’ evolving role.


PBM Consolidation Concerns Medicine for Impacts on Drug Costs, Access - 03/03/2026

Low competition in the pharmacy benefit manager (PBM) market may drive higher costs with savings not fully passed to consumers. Medicine is vigilant as state and federal legislators have started addressing the entities’ evolving role.


PBM Consolidation Concerns Medicine for Impacts on Drug Costs, Access - 03/03/2026

Low competition in the pharmacy benefit manager (PBM) market may drive higher costs with savings not fully passed to consumers. Medicine is vigilant as state and federal legislators have started addressing the entities’ evolving role.


PBM Consolidation Concerns Medicine for Impacts on Drug Costs, Access - 03/03/2026

Low competition in the pharmacy benefit manager (PBM) market may drive higher costs with savings not fully passed to consumers. Medicine is vigilant as state and federal legislators have started addressing the entities’ evolving role.


PBM Consolidation Concerns Medicine for Impacts on Drug Costs, Access - 03/03/2026

Low competition in the pharmacy benefit manager (PBM) market may drive higher costs with savings not fully passed to consumers. Medicine is vigilant as state and federal legislators have started addressing the entities’ evolving role.


PBM Consolidation Concerns Medicine for Impacts on Drug Costs, Access - 03/03/2026

Low competition in the pharmacy benefit manager (PBM) market may drive higher costs with savings not fully passed to consumers. Medicine is vigilant as state and federal legislators have started addressing the entities’ evolving role.


PBM Consolidation Concerns Medicine for Impacts on Drug Costs, Access - 03/03/2026

Low competition in the pharmacy benefit manager (PBM) market may drive higher costs with savings not fully passed to consumers. Medicine is vigilant as state and federal legislators have started addressing the entities’ evolving role.


PBM Consolidation Concerns Medicine for Impacts on Drug Costs, Access - 03/03/2026

Low competition in the pharmacy benefit manager (PBM) market may drive higher costs with savings not fully passed to consumers. Medicine is vigilant as state and federal legislators have started addressing the entities’ evolving role.


PBM Consolidation Concerns Medicine for Impacts on Drug Costs, Access - 03/03/2026

Low competition in the pharmacy benefit manager (PBM) market may drive higher costs with savings not fully passed to consumers. Medicine is vigilant as state and federal legislators have started addressing the entities’ evolving role.


PBM Consolidation Concerns Medicine for Impacts on Drug Costs, Access - 03/03/2026

Low competition in the pharmacy benefit manager (PBM) market may drive higher costs with savings not fully passed to consumers. Medicine is vigilant as state and federal legislators have started addressing the entities’ evolving role.


PBM Consolidation Concerns Medicine for Impacts on Drug Costs, Access - 03/03/2026

Low competition in the pharmacy benefit manager (PBM) market may drive higher costs with savings not fully passed to consumers. Medicine is vigilant as state and federal legislators have started addressing the entities’ evolving role.


PBM Consolidation Concerns Medicine for Impacts on Drug Costs, Access - 03/03/2026

Low competition in the pharmacy benefit manager (PBM) market may drive higher costs with savings not fully passed to consumers. Medicine is vigilant as state and federal legislators have started addressing the entities’ evolving role.


PBM Consolidation Concerns Medicine for Impacts on Drug Costs, Access - 03/03/2026

Low competition in the pharmacy benefit manager (PBM) market may drive higher costs with savings not fully passed to consumers. Medicine is vigilant as state and federal legislators have started addressing the entities’ evolving role.


PBM Consolidation Concerns Medicine for Impacts on Drug Costs, Access - 03/03/2026

Low competition in the pharmacy benefit manager (PBM) market may drive higher costs with savings not fully passed to consumers. Medicine is vigilant as state and federal legislators have started addressing the entities’ evolving role.


PBM Consolidation Concerns Medicine for Impacts on Drug Costs, Access - 03/03/2026

Low competition in the pharmacy benefit manager (PBM) market may drive higher costs with savings not fully passed to consumers. Medicine is vigilant as state and federal legislators have started addressing the entities’ evolving role.